The donation of blood or blood components may not give rise to any direct or indirect remuneration. In addition to any payment in cash, the following are particularly prohibited: any presentation of vouchers, discount coupons or other documents enabling an advantage to be obtained from a third party, as well as any gift of valuable objects, any service or any granting of advantages.
The remuneration paid by the employer to the donor in respect of his professional activity may be maintained during the time devoted to the donation without constituting payment within the meaning of article L. 1211-4, provided that the duration of the absence does not exceed the time required to travel between the place of work and the place of donation and, where applicable, to return, as well as for the…
It is also permitted to give the donor the tokens of recognition provided for by the regulations in force, and to offer a snack following the donation.
The Etablissement Français du Sang is authorised to reimburse blood donors for transport costs incurred during the donation, excluding any flat-rate reimbursement.
Before the pre-donation interview, the candidate fills in a questionnaire, the form and content of which are defined by a decision of the Director General of the Agence nationale de sécurité du médicament et des produits de santé (French Agency for the Safety of Medicines and Health Products), following advice from the Etablissement français du sang (French Blood Establishment) and the Armed Forces Blood Transfusion Centre. At the end of…
The following biological analyses and screening tests are carried out for each donation of blood or blood components intended for the preparation of labile blood products for direct therapeutic use: 1° Erythrocyte blood grouping, which includes : a) Determination of ABO and Rh(D) groups, also known as Rh 1 (RH1) ; b) Determining the Rh phenotype: C(RH2), E(RH3), c(RH4) and e(RH5) and Kell(KEL1) for the first two donations; 2° Testing…
Blood or its components may only be used to prepare labile blood products intended for direct therapeutic use if the results of the screening tests provided for in 5° of article D. 1221-6 are negative.
Derogations from the provisions of articles D. 1221-6 and D. 1221-7 may be provided for by order of the Minister for Health, when blood or its components are collected with a view to preparing labile blood products intended for programmed autologous transfusion.
An order of the Minister for Health may provide for : 1° Biological analyses and screening tests to be carried out for the selection of red cell donors intended to stimulate the synthesis of anti-D antibodies in Rh-immunised plasma donors with a view to the preparation of anti-D immunoglobulins; 2° Biological analyses and screening tests to be carried out for the selection of Rh-immunised plasma donors with a view to…
By way of derogation from the provisions of articles D. 1221-6 to D. 1221-8, an order of the Minister for Health lays down the conditions under which, in order to meet overriding therapeutic needs or to take account of the rarity of certain erythrocyte blood groups, labile blood products for direct therapeutic use, prepared from blood or blood components which have not undergone all the tests and analyses mentioned in…
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Resources
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Useful links
